These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25524973)

  • 1. Growth hormone mitigates loss of periosteal bone formation and muscle mass in disuse osteopenic rats.
    Grubbe MC; Thomsen JS; Nyengaard JR; Duruox M; Brüel A
    J Musculoskelet Neuronal Interact; 2014 Dec; 14(4):473-83. PubMed ID: 25524973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of PTH (1-34) and zoledronate in the prevention of disuse osteopenia in rats.
    Vegger JB; Nielsen ES; Brüel A; Thomsen JS
    Bone; 2014 Sep; 66():287-95. PubMed ID: 24970039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTH (1-34), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats.
    Brüel A; Vegger JB; Raffalt AC; Andersen JE; Thomsen JS
    Bone; 2013 Mar; 53(1):51-8. PubMed ID: 23246791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTH (1-34) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats.
    Brent MB; Brüel A; Thomsen JS
    Bone; 2018 May; 110():244-253. PubMed ID: 29475111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of bone strength is dependent on skeletal site in disuse osteoporosis in rats.
    Thomsen JS; Christensen LL; Vegger JB; Nyengaard JR; Brüel A
    Calcif Tissue Int; 2012 Apr; 90(4):294-306. PubMed ID: 22354132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disuse-induced loss of bone mineral density and bone strength is attenuated by post-lactational bone gain in NMRI mice.
    Sørensen TG; Brent MB; Thomsen JS; Brüel A
    Bone; 2020 Feb; 131():115183. PubMed ID: 31794846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vertical Trabeculae are Thinned More Than Horizontal Trabeculae in Skeletal-Unloaded Rats.
    Vegger JB; Brüel A; Thomsen JS
    Calcif Tissue Int; 2015 Nov; 97(5):516-26. PubMed ID: 26163234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between quantitative X-ray imaging, dual energy X-ray absorptiometry and microCT in the assessment of bone mineral density in disuse-induced bone loss.
    Mabilleau G; Mieczkowska A; Libouban H; Simon Y; Audran M; Chappard D
    J Musculoskelet Neuronal Interact; 2015 Mar; 15(1):42-52. PubMed ID: 25730651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vitamin K2 and growth hormone on the long bones in hypophysectomized young rats: a bone histomorphometry study.
    Iwamoto J; Takeda T; Sato Y; Yeh JK
    J Bone Miner Metab; 2007; 25(1):46-53. PubMed ID: 17187193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-sclerostin antibodies and abaloparatide have additive effects when used as a countermeasure against disuse osteopenia in female rats.
    Brent MB; Brüel A; Thomsen JS
    Bone; 2022 Jul; 160():116417. PubMed ID: 35398589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy-restricted diet benefits body composition but degrades bone integrity in middle-aged obese female rats.
    Shen CL; Zhu W; Gao W; Wang S; Chen L; Chyu MC
    Nutr Res; 2013 Aug; 33(8):668-76. PubMed ID: 23890357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle and bone follow similar temporal patterns of recovery from muscle-induced disuse due to botulinum toxin injection.
    Manske SL; Boyd SK; Zernicke RF
    Bone; 2010 Jan; 46(1):24-31. PubMed ID: 19853070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of risedronate in a rat model of osteopenia due to orchidectomy and disuse: densitometric, histomorphometric and microtomographic studies.
    Libouban H; Blouin S; Moreau MF; Baslé MF; Audran M; Chappard D
    Micron; 2008 Oct; 39(7):998-1007. PubMed ID: 18023586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia.
    Ortoft G; Andreassen TT; Oxlund H
    J Bone Miner Res; 1999 May; 14(5):710-21. PubMed ID: 10320519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rodent model of disuse-induced bone loss by hind limb injection with botulinum toxin A.
    Brent MB; Lodberg A; Thomsen JS; Brüel A
    MethodsX; 2020; 7():101079. PubMed ID: 33083241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term High-Dose Resveratrol Supplementation Reduces Bone Mass and Fracture Strength in Rats.
    Ornstrup MJ; Brüel A; Thomsen JS; Harsløf T; Langdahl BL; Pedersen SB
    Calcif Tissue Int; 2018 Mar; 102(3):337-347. PubMed ID: 29058054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgens have antiresorptive effects on trabecular disuse osteopenia independent from muscle atrophy.
    Laurent MR; Jardí F; Dubois V; Schollaert D; Khalil R; Gielen E; Carmeliet G; Claessens F; Vanderschueren D
    Bone; 2016 Dec; 93():33-42. PubMed ID: 27622887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model.
    Tian X; Jee WS; Li X; Paszty C; Ke HZ
    Bone; 2011 Feb; 48(2):197-201. PubMed ID: 20850580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchiectomized rats.
    Prakasam G; Yeh JK; Chen MM; Castro-Magana M; Liang CT; Aloia JF
    Bone; 1999 May; 24(5):491-7. PubMed ID: 10321909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar.
    Brent MB; Thomsen JS; Brüel A
    Front Endocrinol (Lausanne); 2020; 11():588773. PubMed ID: 33162940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.